![]() |
![]() |
|
|---|---|---|
. |
||
am
and
pm
Tuesday 9
SEPTEMBER |
||||
|
10.30-11.00 COFFEE, TEA, BPC-PJ CAREERS FORUM PRESENTATIONS AND POSTERS
|
||||
|
|
||||
| THE SCIENCE OF PHARMACY | THE PRACTICE OF PHARMACY | STUDENT'S PROGRAMME | ||
|
9.00 - 9.30 Welcoming students: tea and coffee in the exhibition, RPSGB stand |
||||
|
9.30 - 10.00 Conference Science Award |
|
|||
|
In the chair: Andrew Lloyd, BPC 2008 Science
Chair
Liposomes: from delivering vaccines to
improving oil recovery - its all in the formulation |
10.00 - 10.30
Pharmacy Practice Research Trust Practice Research award |
|||
|
|
In the chair: Carmel Hughes, BPC 2008 Practice Chair | |||
|
Exploring the safe and effective supply and
use of non-prescription medicines Margaret Watson, University of Aberdeen |
9.45 - 11.45 Preregistration and undergraduate students Focus on science teaching in MPharm degree courses |
|||
|
11.00 - 11.15 Presentation of the BPC 2009 Science Chair |
||||
| In the chair: Andrew Lloyd, BPC 2008 Science Chair | In the chair: Ian Bates, School of Pharmacy, University of London and James Davies, BPSA President | |||
| Ijeoma Uchegbu, School of Pharmacy, University of London | ||||
|
11.15 - 11.30
Presentation of the BPC 2009 Practice Chair |
Relevance, context and application: the
science of practice Graham Davies, King’s College London |
|||
|
In the chair: Carmel Hughes, BPC 2008
Practice Chair Peter Noyce, University of Manchester |
The science of evidence Phil Wiffen, Cochrane Centre |
|||
|
Students' perspective on science Heena Bhakta, British Pharmaceutical Students’ Association |
||||
|
13.30 - 15.30 A choice of: |
11.30 - 12.00
Keynote address |
|||
| In the chair: Carmel Hughes, BPC 2008 Practice Chair | ||||
| Greening pharmaceutical sciences | ||||
| In the chair: Steve Howdle, University of Nottingham |
Pharmaceutical care in transition: the
evolving role of medicines and pharmacists in the twenty first century NHS
David Taylor, School of Pharmacy, University of London Sponsored by |
|
||
|
13.30 - 15.30 Careers In pharmacy |
||||
|
Green analytical chemistry Mark Harding, Pfizer |
13.30 - 15.30
A choice of |
In the Chair: David Pruce, Director of Policy and Communications, RPSGB | ||
| Supporting pharmacists: from student to practitioner | Question and answer session; topics to include: | |||
|
New approaches to solvent-free synthesis:
cocrystal controlled solid-state synthesis(C3S3) Mike Zaworotko, College of Arts and Sciences, University of South Florida, USA |
Selected papers in pharmacy practice research
Or |
Pharmacy 2020, David Pruce, Director of Policy and Communications, RPSGB |
||
|
The future of the professional body Martin Astbury, Vice-President, RPSGB |
||||
|
Development of food waste products as novel
excipients Dominique Georget, University of East Anglia |
It’s my body: helping children and young people take control of their health and medicines |
The White Paper, Pharmacy in England:
Building on strengths – delivering the future |
||
|
Creating novel drug delivery devices using
supercritical carbon dioxide Steve Howdle, University of Nottingham |
In the chair: Joanne Shaw, Ask About Medicines |
![]() |
||
|
Young people and medicines Jenny Newbould and Felicity Smith, School of Pharmacy, University of London |
||||
| Or |
Empowering children to ask questions about
medicines through schools Claire Callens and Mandy Aspinall, West Midlands Research Network |
|||
| Pharmaceutical sciences: where are we going? |
Talking to adolescents about medicines Nicola Gray, University of Nottingham |
|||
| In association with APS New Scientists Focus Group |
|
|||
| In the chair: Matt Ingram, University of Brighton and Kieran Lennon, AstraZeneca |
I'm the expert on me! Supporting young people
to become expert patients Catherine Wilson: Expert Patient Programme Community Interest Company |
|||
| Tony D'Emannuel (Invited Academic Speaker) - ''The Rough Guide to Academic Pharmacy'' | ||||
| Abstract 123: AJ Croskery - 'Intelligent Anti-Infective Biomaterials' | Or | |||
| A good death-caring for those at the end of their life | ||||
| Abstract 146: S Qi - 'Novel approaches to characterising phase separation and drug distribution across hot melt extruded solid dispersions containing poorly water-soluble drugs' | ||||
| In the chair: Margaret Gibbs, St Christopher’s Hospice | ||||
| Abstract 165: A.A. Elkordy -'Preparation and characteristaion of glibenclamide microcrystals' |
End of life care: meeting the challenge –
making a difference Jo Noble-Gresty, Kensington and Chelsea PCT |
|||
|
Abstract 172: O. Labovitiadi -
'Microbiological (MRSA) and rheological testing of antimicrobial karaya
wafers' |
Approaching the end of life: futile and
inappropriate prescribing and the role of the pharmacist Inga Andrew, Sunderland PCT |
|||
| Mike Hannay (Invited Industrial Speaker) - "Can the pharmaceutical industry afford to fund any more "academic" pharmaceutical science?" |
Happily ever after: the community pharmacist's
role in palliative care Graham Brack, Michael Meagher Ltd, Truro |
|||
| Prize for best presentation to be awarded during this session |
Self care and end of life care: the patient
experience Bridget Johnston, University of Stirling |
|||
| Or | Or | |||
| Predicting oral drug absorption and its variability |
Hot topics in
regulation: the MHRA approach to pseudoephedrine and medical device safety
In association with the Medicines and Healthcare products Regulatory Agency |
|||
| In the chair: Amin Rostami, University of Sheffield | ||||
|
Predicting variability in oral drug
absorption: using systems biology approach and modelling to integrate
information on drug candidates with attributes of an individual patient Amin Rostami, University of Sheffield |
From pseudoephedrine to methylamphetamine
(crystal meth): regulation and the pharmacist Ramila Mistry, Medicines and Healthcare products Regulatory Agency |
|||
|
Solubility as a key factor in determining oral
drug absorption: misconceptions and opportunities for better assessment and integration of information into predictive tools Manuel Sanchez-Felix, Eli Lilly, Indianapolis, USA |
Medical devices: what the pharmacist needs to
know Susanne Ludgate, Medicines and Healthcare products Regulatory Agency |
|||
|
Equilibrium vs kinetic measurements of aqueous
solubility: the assessing supersaturation and rate of precipitation for a
reliable prediction of oral drug absorption John Comer, Sirius Ltd |
The pharmacist’s view Christine Glover, Community pharmacist, Edinburgh |
|||
|
Estimation of dissolution rate: media
conditions for simulating the proximal human gastrointestinal tract and
intragastric juice Christos Reppas, University of Athens, Greece |
|
|||
|
Prediction of oral absorption in humans:
Assessing permeability and incorporating the information into currently
available tools and complexities yet to be addressed Kiyohiko Sugano, Pfizer |
||||
|
Or Combination devices: developments, applications and future directions |
||||
| In the chair: Andy Lewis, Biocompatibles UK Ltd | ||||
|
Coronary stents: the past, present and future Terry Vick, BSCI |
||||
|
Drug eluting beads: a new paradigm for local
drug delivery Brenda Hall, Biocompatibles UK Ltd |
||||
|
Ocular drug delivery Rachel Williams, University of Liverpool |
||||
|
Combination products: antibiotics bone cements Rachael Benson, Smith and Nephew |
||||
| 15.30 CLOSE OF CONFERENCE | ||||
| Top of page ↑ | ||||
| SUNDAY - MONDAY - TUESDAY | ||||
| home - theme - call for papers - programme highlights - full programme - booking - press releases - awards - careers forum - social events | ||||
| . |
|---|